Citation: | HU Bingxue, DONG Xue, FAN Hongwei, ZHU Yongqiang, ZHANG Yin, ZHANG Zhao. Cardiotoxicity evaluation of three novel proteasome inhibitors in zebrafish[J]. Journal of China Pharmaceutical University, 2019, 50(4): 452-458. DOI: 10.11665/j.issn.1000-5048.20190410 |
[1] |
Liang JF,Jin WD,Li HW,et al.In vivo cardiotoxicity induced by sodium aescinate in zebrafish larvae[J].Molecules,2016,21(3):190.
|
[2] |
Kantae V,Krekels EH,Ordas A,et al.Pharmacokinetic modeling of paracetamol uptake and clearance in zebrafish larvae:expanding the allometric scale in vertebrates with five orders of magnitude[J].Zebrafish,2016,13(6):504-510.
|
[3] |
Macrae CA,Peterson RT.Zebrafish as tools for drug discovery[J].Nat Rev Drug Discov,2015,14(10):721-731.
|
[4] |
Wang CM,Wei YJ,Jia XB.Evaluation of antiosteoporotic activity for micro-amount asperosaponins v and vi by on the osteoporosis model using zebrafish[J].J China Pharm Univ(中国药科大学学报),2014,45(1):88-91.
|
[5] |
Brown DR,Clark BW,Garner LV,et al.Zebrafish cardiotoxicity:the effects of CYP1A inhibition and AHR2 knockdown following exposure to weak aryl hydrocarbon receptor agonists[J].Environ Sci Pollut Res Int,2015,22(11):8329-8338.
|
[6] |
Simoneschi D,Simoneschi F,Todd NE.Assessment of cardiotoxicity and effects of malathion on the early development of zebrafish(danio rerio)using computer vision for heart rate quantification[J].Zebrafish,2014,11(3):275-280.
|
[7] |
Li MM,Wang XJ,Zhu JG,et al.Toxic effects of polychlorinated biphenyls on cardiac development in zebrafish[J].Mol Biol Rep,2014,41(12):7973-7983.
|
[8] |
Vargas RA.Effects of GABA,neural regulation,and intrinsic cardiac factors on heart rate variability in zebrafish larvae[J].Zebrafish,2017,14(2):106-117.
|
[9] |
Cornet C, Calzolari S, Miñana-Prieto R, et al. ZeGlobalTox:an innovative approach to address organ drug toxicity using zebrafish[J].Int J Mol Sci,2017,18(4):E864.
|
[10] |
Saley A,Hess M,Miller K,et al.Cardiac toxicity of triclosan in developing zebrafish[J].Zebrafish,2016,13(5):399-404.
|
[11] |
Honton B,Despas F,Dumonteil N,et al.Bortezomib and heart failure:case-report and review of the French Pharmacovigilance database[J].Fundam Clin Pharmacol,2014,28(3):349-352.
|
[12] |
Hasinoff BB,Patel D,Wu X.Molecular mechanisms of the cardiotoxicity of the proteasomal-targeted drugs bortezomib and carfilzomib[J].Cardiovasc Toxicol,2017,17(3):237-250.
|
[13] |
Jouni H,Aubry MC,Lacy MQ,et al.Ixazomib cardiotoxicity:a possible class effect of proteasome inhibitors[J].Am J Hematol,2017,92(2):220-221.
|
[14] |
Manasanch EE,Orlowski RZ.Proteasome inhibitors in cancer therapy[J].Nat Rev Clin Oncol,2017,14(7):417-433.
|
[15] |
Gilda JE,Gomes AV.Proteasome dysfunction in cardiomyopathies[J].J Physiol(Lond),2017,595(12):4051-4071.
|
[16] |
Barac YD,Emrich F,Krutzwakd-Josefson E,et al.The ubiquitin-proteasome system:a potential therapeutic target for heart failure[J].J Heart Lung Transplant,2017,36(7):708-714.
|
[17] |
Food and Drug Administration HHS.International conference on harmonisation;guidance on S7B nonclinical evaluation of the potential for delayed ventricular repolarization(QT interval prolongation)by human pharmaceuticals;availability.notice[J].Fed Regist,2005,70(202):61133-61134.
|
[18] |
Food and Drug Administration,HHS.International conference on Harmonisation;guidance on S7A safety pharmacology studies for human pharmaceuticals;availability.Notice[J].Fed Regist,2001,66(135):36791-36792.
|
[19] |
Genge CE,Lin E,Lee L,et al.The zebrafish heart as a model of mammalian cardiac function[J].Rev Physiol Biochem Pharmacol,2016,171:99-136.
|
[20] |
Zakaria ZZ,Benslimane FM,Nasrallah GK,et al.Using zebrafish for investigating the molecular mechanisms of drug-induced cardiotoxicity[J].Biomed Res Int,2018,2018:164284.
|
[21] |
Milan DJ,Peterson TA,Ruskin JN,et al.Drugs that induce repolarization abnormalities cause bradycardia in zebrafish[J].Circulation,2003,107(10):1355-1358.
|
[1] | WU Jing, YU Xinyue, XU Yan, HUANG Yin, ZHANG Yuxin. Metabolomics profiling of doxorubicin-induced cardiotoxicity in mice with lung injury[J]. Journal of China Pharmaceutical University, 2023, 54(2): 198-207. DOI: 10.11665/j.issn.1000-5048.20221218001 |
[2] | XU Linhao, LIU Xinze, LIU Wei, XIANG Ping, HANG Taijun, YANG Shuo, YAN Hui. Application of zebrafish model in the metabolism of new psychoactive substances[J]. Journal of China Pharmaceutical University, 2022, 53(5): 606-612. DOI: 10.11665/j.issn.1000-5048.20220511 |
[3] | WAN Yili, ZHONG Hui, CHEN Li, SUN Jianbo. Synthesis,anti-melanoma activity and acute toxicity of aporphine alkaloids in zebrafish[J]. Journal of China Pharmaceutical University, 2021, 52(5): 529-535. DOI: 10.11665/j.issn.1000-5048.20210503 |
[4] | LIU Li, PEI Siran, WU Huali, ZHAO Qingshun, PENG Jixian, SHANG Jing. Drug screening model of treating pigmentation disorders in tyrp1a transgenic zebrafish[J]. Journal of China Pharmaceutical University, 2016, 47(6): 740-743. DOI: 10.11665/j.issn.1000-5048.20160618 |
[5] | JIANG Huiyong, YAN Yidan, LIU Haochen, ZHENG Yunsi, WANG Yixuan, HE Hua, LIU Xiaoquan. Evaluation of cardiotoxicity of doxorubicin in rat by a novel metabolic balance model[J]. Journal of China Pharmaceutical University, 2015, 46(2): 224-229. DOI: 10.11665/j.issn.1000-5048.20150215 |
[6] | GAO Xiaoping, CHEN Lixiao, YIN Zhiqi, JIANG Linlin, LIN Qinghua, HE Mingfang. Inhibitory effect of diarylheptanoids from Alpinia oxyphylla on angiogenesis[J]. Journal of China Pharmaceutical University, 2015, 46(1): 85-88. DOI: 10.11665/j.issn.1000-5048.20150112 |
[7] | WANG Changmei, JING Lijun, WEI Yingjie, JIA Xiaobin. Evaluation of antiosteoporotic activity for micro-amount asperosaponins V and VI by on the osteoporosis model using zebrafish[J]. Journal of China Pharmaceutical University, 2014, 45(1): 88-91. DOI: 10.11665/j.issn.1000-5048.20140116 |
[8] | WANG Xiaojian, FU Jihua, TANG Yiqun, YIN Dali, YOU Qidong. Synthesis,biological evaluation and molecule docking of novel desloratadine derivatives[J]. Journal of China Pharmaceutical University, 2013, 44(1): 39-43. DOI: 10.11665/j.issn.1000-5048.20130106 |
[9] | Antagonistic Effects of Extracts from Cultural Mycelium of Cordyceps sinensis on Cardiotoxicity Induced by Ouabain[J]. Journal of China Pharmaceutical University, 2000, (2): 40-42. |
[10] | Colorimetric Determination of Residues of Tricaine in Fish[J]. Journal of China Pharmaceutical University, 1996, (3): 65-66. |
1. |
杜泽飞,张国文,孙健玮. 重楼中皂苷类成分抗肿瘤作用及机制研究进展. 云南医药. 2024(02): 73-75 .
![]() | |
2. |
刘天会. 细胞器之间相互作用在非酒精性脂肪性肝病发生发展中的作用. 临床肝胆病杂志. 2023(01): 181-187 .
![]() | |
3. |
曹守莹. 新型吡啶氮唑氮芥化合物与线粒体的作用及其抗肿瘤活性. 湖北理工学院学报. 2021(01): 56-61 .
![]() |